Life sciences briefing: Tuesday, Feb. 5, 2008

TODAY’S HEADLINES:

Amira Pharma strikes GSK partnership on lung, heart drugs worth up to $425M (release)
Wolters Kluwer Health takes stake in Logical Images (release)
Gentiva Health acquires Home Health Care Affiliates for $55M (release)
Compuware buys Hilgraeve to upgrade

Life sciences briefing: Friday, Jan. 25, 2008

TODAY’S HEADLINES:

Health-info site HealthCentral Network pulls in $50M (paidContent)
BrightHeart Vet corrals $29M to acquire animal hospitals (release)
AviaraDx raises $8M for cancer diagnostics (peHUB)
Valor Medical aims for $15M for brain-aneurysm treatment (VentureWire)
IPC, inpatient-care provider, raises as

Life sciences briefing: Monday, Jan. 14, 2008

TODAY’S HEADLINES:

Autonomic Technologies raises $3M for neurostimulators (PE Hub)
Canopy Financial raises $15M for outsourced healthcare management (release)
Cancer-drug developer AmpliMed draws $5M (PE Hub)
Caprotec Bioanalytics receives €6M for protein-analysis tech (release)
ProtAffin draws additional €1.4M for anti-inflammatory

Life sciences briefing: Tuesday, Jan. 8, 2008

TODAY’S HEADLINES:

CyberHeart pumps in $9M for cardiac-arrhythmia treatment (release)
Incubator ForSight launches third device company with $6M funding (release)
Primera Biosystems raises $21M for molecular diagnostics (release)
Biogen Idec, PDL BioPharma take stakes in Ophthotech (release)
Technitrol acquires medical-device

Life sciences briefing: Thursday, Dec. 27, 2007

TODAY’S HEADLINES:

India’s Perfint, medical-device co., raises $3.5M (release)
Source MDx strikes Pfizer partnership to ID cancer, inflammation “fingerprints” (release)
Columbia River Resources acquires pharma RFID maker Traxxec (release)

India’s Perfint, medical-device co., raises $3.5M – Perfint, a Chennai, India-based …

Cantimer, a nanosensor startup, names new CEO

Menlo Park, Calif.-based Cantimer, a stealthy developer of sensor technology with biomedical, biodefense and consumer applications, named Robin Stracey as its new CEO. The company’s release is here.

Cantimer’s Web site is still a stub, although it describes the company …

Life sciences briefing: Monday, Dec. 10, 2007

TODAY’S HEADLINES:

Fundamental Applied Biology pulls in $21M for proteins without cells (release)
Diagnostics maker Asuragen receives $19M (release)
Stroke-device maker Neurovasx raises $8.5M (release)
Cancer-vaccine maker ImmunoVaccine Tech buys Immunotope, seeks $15M (release)
Vascular imager CardioSpectra sells itself to

Life sciences briefing: Thursday, Dec. 6, 2007

(UPDATED: Expanded items on LineaGen, BG Medicine. Pelikan Tech is described in a standalone item here.)

TODAY’S HEADLINES:

Pelikan Tech raises $69M for diabetes glucose tests (release)
Utah’s LineaGen draws $6M for genetic diagnostics (VentureWire, sub req’d)
Beijing’s IKang

Life sciences briefing: Wednesday, Nov. 28, 2007

Featured companies: American Aerogel, Clinicient, Frazier Healthcare Ventures, Genome Diagnostics, RadPharm, RainDance Technologies, Vivacta

UPDATED: Expanded items on Vitae, RadPharm, Vivacta and Genome Diagnostics. Intelligent Bio-Systems is now covered in a standalone item here.

Vitae Pharma takes in $15M for 

Life sciences briefing: Monday, Oct. 29, 2007

Featured companies: Azaya Therapeutics, Global Care Solutions, Oxford Immunotec, RealSelf.com, Sequoia Pharmaceuticals, Tactile Systems Technology, WellGen, Zeltiq Aesthetics

UPDATED: Expanded items on Oxford Immunotec, Zeltiq, Tactile Systems, RealSelf.com and Global Care.

Oxford Immunotec pulls in $40M for TB tests — 

Life sciences briefing: Thursday, Oct. 18, 2007

Featured companies: American Oriental Bioengineering, Guangxi Boke, Inspired Technologies, Nanosphere, Patton Medical Devices

UPDATED: Expanded items on Nanosphere and Patton Medical Devices.

Molecular-diagnostics firm Nanosphere sets IPO range, now expects $129M — Northbrook, Ill.-based Nanosphere, a maker of nanotech-derived molecular …

Life sciences briefing: Wednesday, Oct. 17, 2007

Featured companies: Algorithme Pharma, Bacchus Vascular, Botaneco, Cubist Pharmaceuticals, Ikonisys, Healthcare Management Systems, Illumigen Biosciences, Kilmer Capital Partners, Medical Specialties Distributors, Metastatix, Microphage, Orthosoft, Thomas McNerney & Partners, TranS1, TriReme Medical, Wren Medical, Zimmer

UPDATE: Expanded TriReme Medical, Ikonisys and 

Life sciences briefing: Tuesday, Oct. 9, 2007

Featured companies: AngioScore, Forsight Labs, Genoptix, Metastatix, Optherion, QLT

UPDATED: See below.

Artery opener AngioScore pulls in $30M — AngioScore, a Fremont, Calif., maker of balloon catheters used to open up clogged arteries, raised $30 million in a fifth funding …

Life sciences briefing: Wednesday, Oct. 3, 2007

Featured companies: Aveo Pharmaceuticals, Aviir, deltaDot, Origen Therapeutics

Heart-diagnostic maker Aviir raises $11.3M — Palo Alto, Calif.-based Aviir, a biotech developing cardiovascular diagnostics based on Stanford research, raised $11.3 million of an expected $25 million second funding round, PE Hub …

Life sciences briefing: Tuesday, Oct. 2, 2007

Featured companies: Change:healthcare, Gemin X Biotechnologies, Ipsogen, the Practice

Change:healthcare raises $1M for health 2.0 sites — Nashville, Tenn.-based change:healthcare, a provider of Web-based health information, raised $1 million in a first funding round. The investment firm Solidus, also based …

Life sciences briefing: Thursday, Sept. 20, 2007

Featured companies: Allergan, Athenahealth, Atria Genetics, Celera, Esprit Pharmaceuticals, Vida Diagnostics

(NOTE: This item was posted on Friday, 9/21/07. I’ve backdated its timestamp to preserve the chronological order of the briefings.)

Celera buys Atria Genetics for $33M — Rockville, …

Life sciences briefing: Wednesday, Sept. 19, 2007

Featured companies: Acceleron Pharma, AdvanDx, Altheus Therapeutics, BiPar Sciences, Coventina Healthcare Enterprises, ForteBio, Ganymed Pharmaceuticals, Mako Surgical, Nile Therapeutics, Novate Medical

[NOTE: This briefing was posted on Friday, 9/21/07; I've edited its timestamp to preserve chronological order among the